Withdrawal of Registration Statement (rw)
29 Mayo 2020 - 4:32PM
Edgar (US Regulatory)
May
29, 2020
Securities
and Exchange Commission
100
F Street, N.E.
Amendment
Number 1 to Registration Statement on Form S-1
Filed
January 8, 2019
Registration
No. 333- 229146 (the “Registration Statement”)
Ordered
Effective February 11, 2019
Ladies
and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended, the undersigned issuer hereby requests that the above captioned Registration
Statement, which was ordered effective on February 11, 2019, be withdrawn. As adjusted for a subsequent 1,000 for 1 reverse
stock split, 15,390 shares were sold under the Registration Statement and 65,860 shares remain unsold. The issuer is withdrawing
the Registration Statement because the issuer does not intend to sell any further shares under the Registration Statement
Very
truly yours,
Endonovo
Therapeutics, Inc.
By:
|
/s/
Alan Collier, CEO
|
|
|
Alan
Collier, CEO
|
|
Endonovo
Therapeutics, Inc., 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA 91367 www.endonovo.com
Endonovo Therapeutics (PK) (USOTC:ENDV)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Endonovo Therapeutics (PK) (USOTC:ENDV)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Endonovo Therapeutics Inc (PK) (OTCMarkets): 0 recent articles
Más de Endonovo Therapeutics, Inc. Artículos de Noticias